Showing results (51-60 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|April 18, 2016
Association of ring box-1 protein overexpression with clinicopathologic prognostic parameters in prostate carcinomaZeliha Esin Celik, Mehmet Kaynar, Fatma Dobur, et al.
Urologic Oncology|July 23, 2015
Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based studyD Robert Siemens, William J Mackillop, Yingwei Peng, et al.
Urologic Oncology|August 9, 2016
Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapiesTian Zhang, Jason Zhu, Daniel J George, et al.
Urologic Oncology|February 11, 2025
SIRI as a biomarker for bladder neoplasm: Utilizing decision curve analysis to evaluate clinical net benefitPierluigi Russo, Nazario Foschi, Giuseppe Palermo, et al.
Urologic Oncology|February 11, 2025
Reducing infectious complications and healthcare costs in transrectal ultrasound-guided prostate biopsy with single-dose cefmetazole and levofloxacinKatsuhiro Onishi, Hiroshi Morioka, Kazuki Nishida, et al.
Urologic Oncology|January 17, 2025
Clinical translation of the interconnected role of the microbiome and diet in genitourinary malignanciesKaren S Sfanos
Urologic Oncology|January 11, 2025
Can parenchymal volume analysis replace nuclear renal scans for split renal function before and after partial nephrectomy with warm ischemia?Yixin Huang, Ming Gao, Yanjun Wang, et al.
Urologic Oncology|January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Urologic Oncology|January 10, 2025
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer managementNicole A Metri, Adel Mandl, Channing J Paller
Urologic Oncology|November 26, 2024
The efficacy of sequential intravesical gemcitabine and docetaxel versus BCG for the treatment of European association of urology very-high risk non-muscle invasive bladder cancerMohamad Abou Chakra, Vignesh T Packiam, Ian M McElree, et al.
Pageof 487